Ferguson GT - Search Results

1

Effect of Inhaled Corticosteroid Withdrawal on Chronic Obstructive Pulmonary Disease Exacerbations in Patients Taking Triple Therapy at Baseline.

Ferguson GT, Shaikh A, Tetzlaff K, Mueller A, Magnussen H, Watz H. Ferguson GT, et al. Int J Chron Obstruct Pulmon Dis. 2020 Nov 11;15:2879-2888. doi: 10.2147/COPD.S237408. eCollection 2020. Int J Chron Obstruct Pulmon Dis. 2020. PMID: 33204084 Free PMC article.

2

COPD patient satisfaction with ipratropium bromide/albuterol delivered via Respimat: a randomized, controlled study.

Ferguson GT, Ghafouri M, Dai L, Dunn LJ. Ferguson GT, et al. Int J Chron Obstruct Pulmon Dis. 2013;8:139-50. doi: 10.2147/COPD.S38577. Epub 2013 Mar 19. Int J Chron Obstruct Pulmon Dis. 2013. PMID: 23658479 Free PMC article. Clinical Trial.

3

Efficacy and safety of olodaterol once daily delivered via Respimat® in patients with GOLD 2-4 COPD: results from two replicate 48-week studies.

Ferguson GT, Feldman GJ, Hofbauer P, Hamilton A, Allen L, Korducki L, Sachs P. Ferguson GT, et al. Int J Chron Obstruct Pulmon Dis. 2014 Jun 16;9:629-45. doi: 10.2147/COPD.S61717. eCollection 2014. Int J Chron Obstruct Pulmon Dis. 2014. PMID: 24966672 Free PMC article. Clinical Trial.

4

One-Year Safety of Olodaterol Once Daily via Respimat® in Patients with GOLD 2-4 Chronic Obstructive Pulmonary Disease: Results of a Pre-Specified Pooled Analysis.

McGarvey L, Niewoehner D, Magder S, Sachs P, Tetzlaff K, Hamilton A, Korducki L, Bothner U, Vogelmeier C, Koch A, Ferguson GT. McGarvey L, et al. Among authors: ferguson gt. COPD. 2015;12(5):484-93. doi: 10.3109/15412555.2014.991864. Epub 2015 Feb 18. COPD. 2015. PMID: 25692310 Free PMC article. Clinical Trial.

5

Efficacy of Tiotropium + Olodaterol in Patients with Chronic Obstructive Pulmonary Disease by Initial Disease Severity and Treatment Intensity: A Post Hoc Analysis.

Ferguson GT, Fležar M, Korn S, Korducki L, Grönke L, Abrahams R, Buhl R. Ferguson GT, et al. Adv Ther. 2015 Jun;32(6):523-36. doi: 10.1007/s12325-015-0218-0. Epub 2015 Jun 26. Adv Ther. 2015. PMID: 26112656 Free PMC article. Clinical Trial.

6

Effects of tiotropium + olodaterol versus tiotropium or placebo by COPD disease severity and previous treatment history in the OTEMTO® studies.

Singh D, Gaga M, Schmidt O, Bjermer L, Grönke L, Voß F, Ferguson GT. Singh D, et al. Among authors: ferguson gt. Respir Res. 2016 Jun 18;17(1):73. doi: 10.1186/s12931-016-0387-7. Respir Res. 2016. PMID: 27316465 Free PMC article.

7

Efficacy and safety of tiotropium + olodaterol maintenance treatment in patients with COPD in the TONADO^® and OTEMTO^® studies: a subgroup analysis by age.

Ferguson GT, Karpel JP, Clerisme-Beaty E, Grönke L, Voß F, Buhl R. Ferguson GT, et al. Int J Chron Obstruct Pulmon Dis. 2016 Oct 31;11:2701-2710. doi: 10.2147/COPD.S108758. eCollection 2016. Int J Chron Obstruct Pulmon Dis. 2016. PMID: 27843306 Free PMC article.

8

A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease.

Reisner C, Fabbri LM, Kerwin EM, Fogarty C, Spangenthal S, Rabe KF, Ferguson GT, Martinez FJ, Donohue JF, Darken P, St Rose E, Orevillo C, Strom S, Fischer T, Golden M, Dwivedi S. Reisner C, et al. Among authors: ferguson gt. Respir Res. 2017 Jan 6;18(1):8. doi: 10.1186/s12931-016-0491-8. Respir Res. 2017. PMID: 28061907 Free PMC article. Clinical Trial.

9

Effect of tiotropium and olodaterol on symptoms and patient-reported outcomes in patients with COPD: results from four randomised, double-blind studies.

Ferguson GT, Karpel J, Bennett N, Clerisme-Beaty E, Grönke L, Voß F, Buhl R. Ferguson GT, et al. NPJ Prim Care Respir Med. 2017 Feb 2;27(1):7. doi: 10.1038/s41533-016-0002-x. NPJ Prim Care Respir Med. 2017. PMID: 28154373 Free PMC article. Clinical Trial.

10

Long-term safety of glycopyrrolate/eFlow^® CS in moderate-to-very-severe COPD: Results from the Glycopyrrolate for Obstructive Lung Disease via Electronic Nebulizer (GOLDEN) 5 randomized study.

Ferguson GT, Goodin T, Tosiello R, Wheeler A, Kerwin E. Ferguson GT, et al. Respir Med. 2017 Nov;132:251-260. doi: 10.1016/j.rmed.2017.08.020. Epub 2017 Aug 24. Respir Med. 2017. PMID: 28919143 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

134 results

Search Page

Filters